Seroba Life Sciences Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
6
- Investments
-
57
- Portfolio
-
12
- Exits
-
20
Seroba Life Sciences General Information
Description
Founded in 2009, Seroba Life Sciences is a venture capital firm based in Dublin, Ireland. The firm seeks to invest in the healthcare sector.
Contact Information
Website
www.seroba-lifesciences.com
Year Founded
2009
Investor Status
Actively Seeking New Investments
Trade Association
Irish Venture Capital Association (IVCA)
Primary Investor Type
Venture Capital
Primary Office
- 18 Herbert Street
- Dublin D02 FK19
- Ireland
+353 (01) 000 0000
Seroba Life Sciences Investments (57)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Perfuze | 09-Feb-2022 | Early Stage VC | 000.00 | Surgical Devices | Clinical Trials - General | 000000 0'000000 00.0 |
| 00000 000000000000 | 21-Jul-2021 | 00000 00000 | 000.00 | Drug Delivery | Generating Revenue | 00000 000000000 00.0 |
| 00000000 | 28-Jun-2021 | 00000 00000 | 00.000 | Surgical Devices | Generating Revenue | 00000000 0000000 |
| 000000 | 23-Jun-2021 | 00000 00000 | 00000 | Other Devices and Supplies | Generating Revenue | 00000 000000 |
| 000000 00000000 | 16-Feb-2021 | 00000 00000 | 00.00 | Drug Discovery | Generating Revenue/Not Profitable | 0000 0'0000000 00.0 |
| 0000000000 | 24-Sep-2019 | 00000 00000 | 000.00 | Decision/Risk Analysis | Generating Revenue | 00000000 0000000 |
| 000000 | 29-Jul-2019 | 00000 00000 | 0000 | Other Devices and Supplies | Generating Revenue | 00000 000000 |
| 00000 000000000000 | 20-May-2019 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | 00000 000000000 00.0 |
| Fusion Pharmaceuticals | 25-Mar-2019 | Early Stage VC | 00000 | Drug Discovery | Generating Revenue/Not Profitable | 0000 0'0000000 00.0 |
| PQ Bypass | 14-Jan-2019 | Later Stage VC | 0000 | Surgical Devices | Generating Revenue | 000000 0'000000 00.0 |
Seroba Life Sciences Exits (20)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| PQ Bypass | 13-Apr-2021 | Merger/Acquisition | |
| 000000 00000000000 | 26-Jun-2020 | 000 | 00000 |
| 0000000000000000 0 | 25-Jun-2020 | 000000000000000000 | 00000 |
| 0000 000000 | 01-Oct-2019 | 000 00 00000000 | |
| 0000000 | 30-Jan-2019 | 000000000000000000 | |
| 000000 00000000000 | 13-Jan-2019 | 0000000000: 000000 | |
| 000000 | 13-Dec-2018 | 000000000000000000 | |
| 000000 0000000 000 | 07-Sep-2018 | 000000000000000000 | 00000 |
| Biosensia | 13-Jul-2018 | Merger/Acquisition | |
| Prexton Therapeutics | 16-Mar-2018 | Merger/Acquisition | 00000 |
Seroba Life Sciences Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Seroba Life Sciences Team (10)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Alan O'Connell Ph.D | Partner | 00 | 0 | 0 | Dublin, Ireland |
| Daniel O'Mahony Ph.D | Partner | 00 | 0 | 0 | Dublin, Ireland |
| Andrew Duignan | Chief Financial Officer | Dublin, Ireland | |||
| Bruno Montanari Ph.D | Partner | 00 | 00 | 0 | Dublin, Ireland |
| Jennifer McMahon | Partner | 0 | 0 | 0 | Dublin, Ireland |
Seroba Life Sciences Co-Investors (75)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| EQT Life Sciences | 3 | 0 |
|
|
|
| Earlybird Venture Capital | 0 | 0 |
|
|
|
| Enterprise Ireland | 0 | 0 |
|
|
|
| Lumira Ventures | 0 | 0 |
|
|
|
| SV Health Investors | 0 | 0 |
|
|